AI in Bio/Pharma Supply Chain: SK pharmteco Expert Shares Insights at DCAT Week
At DCAT Week, the buzz wasn’t just about the latest drug discovery techniques – it was about AI’s growing influence
News
From The Korea Economic Daily: SK pharmteco Launches New Viral Vector Platforms, Key for CGT
The Korean CDMO’s new viral vector platforms can significantly save the production time and cost of AAV and lentiviral vectors
SK pharmteco’s subsidiary Yposkesi launches AAVelocity, a plug-and-play Adeno-Associated Virus (AAV) platform
Designed to shorten turnaround on manufacturing AAVs, this new platform offers Cell and Gene Therapy developers more flexibility in producing
